You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

9-ing-41

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Adenocarcinoma Trial in Fairway (9-ING-41, Retifanlimab, Gemcitabine)

Active, not recruiting
  • Pancreatic Adenocarcinoma
  • 9-ING-41
  • +3 more
  • Fairway, Kansas
    Kansas University Cancer center
Nov 2, 2022

Refractory Cancer, Refractory Tumor, Cancer Pediatric Trial in United States (9-ING-41, Irinotecan, Temozolomide)

Recruiting
  • Refractory Cancer
  • +10 more
  • 9-ING-41
  • +4 more
  • Aurora, Colorado
  • +7 more
Dec 31, 2022

Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic Trial in Boston (FOLFIRNINOX, Losartan, 9-ING-41)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Adenocarcinoma Metastatic
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jun 7, 2022

Salivary Gland Carcinoma, Adenoid Cystic Carcinoma, Salivary Gland Cancer Trial in Boston (9-ING-41, Carboplatin)

Withdrawn
  • Salivary Gland Carcinoma
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Feb 5, 2022

Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer Trial in Boston (9-ING-41, Carboplatin)

Recruiting
  • Salivary Gland Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Oct 15, 2021

Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,

Withdrawn
  • Soft Tissue Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Nov 30, 2021

Sarcoma, Soft Tissue Sarcoma, Metastatic Sarcoma Trial in Providence (Gemcitabine, Docetaxel, 9-ING-41)

Withdrawn
  • Sarcoma
  • +12 more
  • Providence, Rhode Island
  • +1 more
Jul 26, 2021